GeoVax Labs

+$0.0278 (+3.53%) As of 2:22 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GeoVax Labs and other ETFs, options, and stocks.

About GOVX

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies and vaccines against cancers and infectious diseases using a novel vector vaccine platform. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever, the Zika virus and malaria, and human immunodeficiency virus (HIV), as well as immunotherapies for solid tumor cancers.

CEO
David A. Dodd
Employees
11
Headquarters
Smyrna, Georgia
Founded
1988

GOVX Key Statistics

Market cap
10.24M
Price-Earnings ratio
—
Dividend yield
—
Average volume
2.71M
High today
$0.8199
Low today
$0.78
Open price
$0.78
Volume
388.33K
52 Week high
$7.50
52 Week low
$0.5495

GOVX Earnings

-$2.24
-$1.49
-$0.75
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure